Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Sedation in Total Knee Arthroplasty
NCT04859283Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in postoperative pain, anxiety disorder, sponsored by Turku University Hospital. Started Jun 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painanxiety disorder
Beyond the preview
Go deeper on NCT04859283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04859283.